SCHEMBL20733737

SCHEMBL20733737

c1ccc2cc(-c3nnc4c5cccnc5c5ccccc5c4n3)ccc2c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.43
▸ CYP17A1 P05093 1/20 0.41
▸ CYP19A1 P11511 1/20 0.41
▸ CYP11B1 P15538 1/20 0.41
▸ CYP11B2 P19099 1/20 0.41
▸ SMN1; SMN2 Q16637 4/20 0.40
▸ LMNA P02545 3/20 0.40
▸ KDM4E B2RXH2 3/20 0.40
▸ TP53 P04637 3/20 0.40
▸ MAPT P10636 2/20 0.40
▸ TSHR P16473 2/20 0.40
▸ NPSR1 Q6W5P4 2/20 0.40
▸ HSD17B10 Q99714 2/20 0.40
▸ PKM P14618 1/20 0.40
▸ KLF5 Q13887 1/20 0.40
▸ CCR1 P32246 3/20 0.39
▸ CCR8 P51685 3/20 0.39
▸ CYP3A4 P08684 2/20 0.39
▸ GMNN O75496 1/20 0.39
▸ HSP90AA1 P07900 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20733790 0.87 ALDH1A1 (0.41) ALDH1A1SMN1; SMN2LMNAKDM4ETP53
SCHEMBL20733789 0.87 ALDH1A1 (0.41) ALDH1A1SMN1; SMN2LMNAKDM4ETP53
SCHEMBL20733802 0.82 L3MBTL1 (0.39) ALDH1A1SMN1; SMN2LMNAKDM4ETP53
SCHEMBL20733736 0.82 ALDH1A1 (0.37) ALDH1A1CYP11B1MAPTCCR1CCR8
SCHEMBL20733851 0.81 L3MBTL1 (0.41) ALDH1A1SMN1; SMN2LMNAKDM4ETP53
SCHEMBL12761842 0.78 NPC1 (0.45) ALDH1A1SMN1; SMN2LMNAKDM4ETP53
SCHEMBL20733852 0.78 GP6 (0.41) ALDH1A1CCR1CCR8HSP90AA1HIF1A
SCHEMBL20733738 0.78 ALDH1A1 (0.44) ALDH1A1CYP11B1SMN1; SMN2LMNAKDM4E
SCHEMBL20733796 0.77 L3MBTL1 (0.48) ALDH1A1SMN1; SMN2LMNAKDM4ETP53
SCHEMBL20733872 0.77 ALDH1A1 (0.35) ALDH1A1CYP11B1SMN1; SMN2LMNAKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230057590-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION 2023-02-23 — — US disclosed
US-20190051842-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION 2019-02-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230057590-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES OCIAD2, OCIAD1, OXER1 ALDH1A1 1010/4885CYP17A1 3157/4885CYP19A1 1512/4885
US-20190051842-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES OCIAD2, OCIAD1, OXER1 ALDH1A1 1010/4885CYP17A1 3157/4885CYP19A1 1512/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback